San Diego, CA - A substudy of the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial indicates that amiodarone is the most effective drug in terms of keeping patients ...
Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback